After two days of declines, shares of Bright Minds Biosciences (NASDAQ:DRUG) bounced back in the premarket on Friday with a ~48% rise after the psychedelic drug developer announced a private ...

Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the ...

Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 ...

VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) is pleased to announce a non ...

This full moon is also particularly bright in the sky, giving hunters greater opportunity to stalk prey at night.

If you drop your iPhone's screen brightness to the bottom and it's still too bright, there's a hidden setting that can make it even dimmer. Nelson Aguilar is an LA-based tech how-to writer and ...

Bright Minds' drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating ...

Bright Minds says nothing has material has changed in response to the stock move. Psychedelic drug company Bright Minds Biosciences Inc. (NASDAQ: DRUG) saw its stock rocket higher by 1,445% to close ...

Trisha Jandoc is an associate writer at CNET covering broadband and everything related to home internet. She graduated from St. John's University with a bachelor's degree in journalism and a focus ...